[Cardioprotective effect of cytoflavine on a model of doxorubicin-induced cardiomyopathy]

Eksp Klin Farmakol. 2010 Mar;73(3):15-7.
[Article in Russian]

Abstract

Experimental data on the influence of repeated administration of doxorubicin in a dose of 2.24 mg/kg on the glutathione exchange in heart tissues and erythrocytes of white outbred rats are presented. It was shown that disorders in the natural cytoprotection system caused by the introduction of this cardiotropic agent, can be corrected using a combined preparation of cytoflavin.

Publication types

  • English Abstract

MeSH terms

  • Animals
  • Cardiomyopathies / chemically induced
  • Cardiomyopathies / drug therapy*
  • Cardiomyopathies / metabolism
  • Cardiotonic Agents / pharmacology*
  • Cardiotonic Agents / therapeutic use
  • Cytoprotection
  • Doxorubicin*
  • Drug Combinations
  • Erythrocytes / drug effects
  • Erythrocytes / metabolism
  • Flavin Mononucleotide / pharmacology*
  • Flavin Mononucleotide / therapeutic use
  • Glutathione / metabolism
  • Inosine Diphosphate / pharmacology*
  • Inosine Diphosphate / therapeutic use
  • Lipid Peroxidation / drug effects
  • Male
  • Myocardium / metabolism
  • Niacinamide / pharmacology*
  • Niacinamide / therapeutic use
  • Rats
  • Succinates / pharmacology*
  • Succinates / therapeutic use

Substances

  • Cardiotonic Agents
  • Drug Combinations
  • Succinates
  • cytoflavin
  • Niacinamide
  • Flavin Mononucleotide
  • Doxorubicin
  • Inosine Diphosphate
  • Glutathione